- Home
- HOWL vs CATO Comparison
HOWL vs CATO Comparison
Compare HOWL & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- CATO
- Stock Information
- Founded
- HOWL 2017
- CATO 1946
- Country
- HOWL United States
- CATO United States
- Employees
- HOWL N/A
- CATO N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- CATO Clothing/Shoe/Accessory Stores
- Sector
- HOWL Health Care
- CATO Consumer Discretionary
- Exchange
- HOWL Nasdaq
- CATO Nasdaq
- Market Cap
- HOWL 64.5M
- CATO 57.6M
- IPO Year
- HOWL 2021
- CATO N/A
- Fundamental
- Price
- HOWL $1.40
- CATO $4.64
- Analyst Decision
- HOWL Strong Buy
- CATO
- Analyst Count
- HOWL 5
- CATO 0
- Target Price
- HOWL $7.20
- CATO N/A
- AVG Volume (30 Days)
- HOWL 151.8K
- CATO 204.6K
- Earning Date
- HOWL 11-06-2025
- CATO 08-21-2025
- Dividend Yield
- HOWL N/A
- CATO N/A
- EPS Growth
- HOWL N/A
- CATO N/A
- EPS
- HOWL N/A
- CATO N/A
- Revenue
- HOWL N/A
- CATO $650,830,000.00
- Revenue This Year
- HOWL N/A
- CATO N/A
- Revenue Next Year
- HOWL N/A
- CATO N/A
- P/E Ratio
- HOWL N/A
- CATO N/A
- Revenue Growth
- HOWL N/A
- CATO N/A
- 52 Week Low
- HOWL $0.60
- CATO $2.19
- 52 Week High
- HOWL $4.18
- CATO $6.70
- Technical
- Relative Strength Index (RSI)
- HOWL 56.16
- CATO 68.86
- Support Level
- HOWL $1.38
- CATO $3.84
- Resistance Level
- HOWL $1.49
- CATO $4.73
- Average True Range (ATR)
- HOWL 0.07
- CATO 0.26
- MACD
- HOWL 0.00
- CATO -0.00
- Stochastic Oscillator
- HOWL 55.00
- CATO 73.33
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.